Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Windyga

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrateE Berntorp, J Windyga,
Thrombosis and Haemostasis|March 26, 2011
Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgeryJ Windyga, M von Depka-Prondzinski,
Acta Haematologica Polonica|January 1, 1996
[Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia]J Windyga, L Rzymkiewicz, S Lopaciuk
Polskie Archiwum Medycyny Wewnetrznej|July 4, 2001
[Prevalence of G20210A prothrombin gene mutation in Poland]K Bykowska, B Vertun-Baranowska, J Windyga, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 27, 2016
Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitorsJ Windyga, E Stefanska-Windyga, E Odnoczko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 1, 2012
Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimenJ Windyga, P Zbikowski, P Ambroziak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 3, 2014
Total elbow arthroplasty in patient with severe von Willebrand diseaseI Kotela, P Zbikowski, P Ambroziak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Helicobacter pylori infection in patients with haemophilia in Poland: prevalence and risk of upper gastrointestinal bleedingA B Szczepanik, M Zaleska, A Wiszniewski, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrateE Berntorp, J Windyga,
Thrombosis and Haemostasis|March 26, 2011
Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgeryJ Windyga, M von Depka-Prondzinski,
Acta Haematologica Polonica|January 1, 1996
[Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia]J Windyga, L Rzymkiewicz, S Lopaciuk
Polskie Archiwum Medycyny Wewnetrznej|July 4, 2001
[Prevalence of G20210A prothrombin gene mutation in Poland]K Bykowska, B Vertun-Baranowska, J Windyga, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 27, 2016
Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitorsJ Windyga, E Stefanska-Windyga, E Odnoczko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 1, 2012
Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimenJ Windyga, P Zbikowski, P Ambroziak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 3, 2014
Total elbow arthroplasty in patient with severe von Willebrand diseaseI Kotela, P Zbikowski, P Ambroziak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Helicobacter pylori infection in patients with haemophilia in Poland: prevalence and risk of upper gastrointestinal bleedingA B Szczepanik, M Zaleska, A Wiszniewski, et al.
Pageof 5